Lincare was founded in 1972 as a spinoff from Union Carbide. The company provides oxygen and oxygen supplies, as well as respiratory therapy services.
The Linde Group acquired Lincare in August 2012 for an estimated $41.50 per share.
The leading provider of respiratory health aides and services, Lincare is playing a large role during the COVID-19 crisis, providing oxygen to patients at home and creating space in hospital facilities by transferring respiratory patients from in-patient care to in-home care.
The company provides services under several names, including Medilink, Med-Home, and American HomePatient.
Lincare continues to expand despite the fact that the 1997 Balanced Budget Act put a cap on Medicare and Medicaid reimbursements on the services it provides. Medicare and Medicaid payments account for approximately 60% of the company’s revenue. In addition to providing oxygen, the company also provides infusion therapy, palliative care, hydration therapy, chemotherapy, AIDS-related therapies, inhalation therapy, and enteral and parenteral nutritional care; and some home-use medical equipment, including ventilators, wheelchairs, walkers, and hospital beds.
Lincare and other in-home health services corporations are expecting explosive growth through 2026.
Lincare maintains a corporate office in Clearwater, Florida.